Cargando…
Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis
BACKGROUND: There is currently no single treatment that mitigates all harms caused by severe acute respiratory syndrome coronavirus 2 infection. Tocilizumab, an interleukin-6 antagonist, may have a role as an adjunctive immune-modulating therapy. METHODS: This was an observational retrospective stud...
Autores principales: | Ignatius, Elisa H, Wang, Kunbo, Karaba, Andrew, Robinson, Matthew, Avery, Robin K, Blair, Paul, Chida, Natasha, Jain, Tania, Petty, Brent G, Siddiqui, Zishan, Melia, Michael T, Auwaerter, Paul G, Xu, Yanxun, Garibaldi, Brian T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798657/ https://www.ncbi.nlm.nih.gov/pubmed/33537364 http://dx.doi.org/10.1093/ofid/ofaa598 |
Ejemplares similares
-
Misdiagnosis of Lyme Disease With Unnecessary Antimicrobial Treatment Characterizes Patients Referred to an Academic Infectious Diseases Clinic
por: Kobayashi, Takaaki, et al.
Publicado: (2019) -
Characteristics and Treatment Outcomes of Propionibacterium acnes Prosthetic Shoulder Infections in Adults
por: Piggott, Damani A., et al.
Publicado: (2015) -
Defining Clinical Excellence in Adult Infectious Disease Practice
por: Chida, Natasha M., et al.
Publicado: (2016) -
Geographic Influence Upon Noninfectious Diseases Accounting for Fever of Unknown Origin: A Systematic Review and Meta-Analysis
por: Wright, William F, et al.
Publicado: (2022) -
Investigator-Determined Categories for Fever of Unknown Origin (FUO) Compared With International Classification of Diseases–10 Classification of Illness: A Systematic Review and Meta-analysis With a Proposal for Revised FUO Classification
por: Wright, William F, et al.
Publicado: (2023)